Healthcare Finance — Development

Every healthcare finance — development case is shaped by three constraints at once: what the security supports, what the borrower can evidence, and how quickly funds are needed. A healthcare scheme is not finished at practical completion: registration is the milestone that creates value, and lenders size the facility around it.

Structurally, the facility is secured on a first charge over the site, supported by a debenture and personal or corporate guarantees, written over terms of nine to twenty-four months, aligned to the build programme plus a sales period, with typically up to 60% of gross development value, held below general residential development because value depends on registration and an operator being in place. Lenders assess the exit before the entry: the facility is repaid by refinancing onto a healthcare term loan once registration is granted and occupancy is established, or from a sale to an operator or healthcare investor. That ordering explains why two applicants with identical income can receive materially different terms — the credit question is whether the repayment route survives a slower market, not whether the borrower looks creditworthy today.

Activity in this segment comes from institutional debt funds targeting the care sector, clearing bank healthcare desks with construction capability and specialist care lenders funding purpose-built schemes. Each prices the same healthcare finance case against its own funding cost and risk appetite, which is why the same healthcare finance — development case can attract offers several percentage points apart. The Financial Conduct Authority supervision shapes conduct standards and, where the borrowing is regulated, the advice and disclosure obligations that sit around the transaction.

The nearest alternatives are acquiring an existing registered home rather than building, a forward-funding arrangement with a healthcare investor and extending an existing home in phases funded from trading. Each solves a slightly different problem: some are cheaper but slower, others are faster but priced for short exposure, and a few avoid taking a charge over the asset altogether. The right comparison is total cost over the period the money is actually needed.

Where the requirement is short and the exit is certain, a short-dated facility usually wins on total cost even at a higher rate, because the interest is charged for months rather than years. Where the asset is held for the long term and the income is stable, the opposite is true and a term facility priced on a margin plus arrangement and exit fees, with interest charged only on funds drawn rather than on the full facility is the cheaper way to hold the position. A healthcare scheme is not finished at practical completion: registration is the milestone that creates value, and lenders size the facility around it.

A broker or adviser adds most value at this point rather than at application. Comparing institutional debt funds targeting the care sector, clearing bank healthcare desks with construction capability and specialist care lenders funding purpose-built schemes on a like-for-like basis, including fees and exit terms, is the step that determines the cost of the transaction — the paperwork that follows is largely administrative.

Eligibility for healthcare finance — development is assessed on the asset first and the applicant second. Lenders test the appraisal tested against a registration timetable and a lease-up curve, with an operator agreement or experienced in-house operator required before terms are issued, then satisfy themselves that the facility is repaid by refinancing onto a healthcare term loan once registration is granted and occupancy is established, or from a sale to an operator or healthcare investor remains achievable under stressed assumptions. Trading history, sector, and the quality of the security all move the answer, and a marginal case is far more often declined on evidence gaps than on the underlying numbers.

A complete submission normally contains a cost appraisal separating clinical fit-out from base build, planning consent together with the registration standards the scheme is designed to and the operator agreement, or evidence of the developer's own registered operations. Where any of these are missing, underwriters price the uncertainty rather than ignore it, so incomplete packs tend to return higher rates or lower advances rather than an outright refusal. Preparing the pack before approaching lenders is the single most effective way to protect the terms available.

Where the pack is thinner, underwriters ask for a cost appraisal separating clinical fit-out from base build and planning consent together with the registration standards the scheme is designed to before they will commit, because those items evidence the part of the case the security cannot. A healthcare scheme is not finished at practical completion: registration is the milestone that creates value, and lenders size the facility around it. The trade-off is cost: flexibility on criteria is almost always paid for in margin, fees, or a lower advance against value.

An application moves through four stages: an initial assessment of security and requirement, a terms sheet or decision in principle, valuation and legal due diligence, then formal offer and drawdown. Healthcare development terms usually follow in two to three weeks, with drawdown after registration planning, monitoring surveyor sign-off and operator agreement in eight to twelve weeks. The valuation and legal stage accounts for most of the elapsed time and is where avoidable delays occur.

Preparation shortens the timetable more than lender selection does. Having planning consent together with the registration standards the scheme is designed to, the operator agreement, or evidence of the developer's own registered operations and a cost appraisal separating clinical fit-out from base build ready at enquiry allows a lender to issue terms on evidence rather than assumption, and reduces the number of conditions attached to the offer. Instructing solicitors experienced in healthcare finance at the same time prevents the legal work starting from a standing position after the offer arrives.

Conditions precedent are normal and usually procedural: confirmation of insurance, satisfactory searches over a first charge over the site, supported by a debenture and personal or corporate guarantees, and evidence of the deposit or contribution. Treating them as a checklist to clear in parallel, rather than in sequence, is the practical difference between a transaction that completes on time and one that requires an extension.

Consider a borrower using healthcare finance — development where a surgery or clinic is built to meet a specific commissioning need. The starting point is the security: an independent valuation establishes what the asset supports, and typically up to 60% of gross development value, held below general residential development because value depends on registration and an operator being in place sets the realistic ceiling on the facility. The gap between the ceiling and the funds required is the equity or additional security the borrower must contribute.

The facility is then sized against the appraisal tested against a registration timetable and a lease-up curve, with an operator agreement or experienced in-house operator required before terms are issued, and the term is set by the repayment route rather than by preference — the facility is repaid by refinancing onto a healthcare term loan once registration is granted and occupancy is established, or from a sale to an operator or healthcare investor. Costs are modelled across the full term, including arrangement and exit fees, so the comparison against alternatives is made on total cost rather than on headline rate.

Two details decide whether that structure holds. The first is documentary: planning consent together with the registration standards the scheme is designed to, the operator agreement, or evidence of the developer's own registered operations and a cost appraisal separating clinical fit-out from base build must support the figures rather than follow them. The second is timing — healthcare development terms usually follow in two to three weeks, with drawdown after registration planning, monitoring surveyor sign-off and operator agreement in eight to twelve weeks. — because every week the facility runs beyond plan is charged at the facility rate rather than at the rate the borrower budgeted.

This example is illustrative. It is not a quotation, a recommendation, or evidence of available terms; actual pricing depends on valuation, credit assessment, and the lender's appetite on the day. Its purpose is to show the order in which decisions are made, because borrowers who understand that sequence present far stronger applications.

Pricing is built rather than quoted. The headline rate reflects a margin plus arrangement and exit fees, with interest charged only on funds drawn rather than on the full facility, and the effective cost only becomes visible once arrangement fees, valuation and legal costs, and any exit or early-repayment charge are added to the same calculation. Comparing two offers on rate alone routinely selects the more expensive facility.

Three variables move the price materially: where the request sits against typically up to 60% of gross development value, held below general residential development because value depends on registration and an operator being in place, how the appraisal tested against a registration timetable and a lease-up curve, with an operator agreement or experienced in-house operator required before terms are issued is evidenced, and the time the lender is exposed before the facility is repaid by refinancing onto a healthcare term loan once registration is granted and occupancy is established, or from a sale to an operator or healthcare investor. Reducing the advance is usually the most efficient lever, because it lowers loss-given-default for the lender and therefore the margin charged. Figures discussed at enquiry stage are indicative and subject to valuation and full underwriting.

Borrowers should also price the cost of delay. Healthcare development terms usually follow in two to three weeks, with drawdown after registration planning, monitoring surveyor sign-off and operator agreement in eight to twelve weeks. A healthcare scheme is not finished at practical completion: registration is the milestone that creates value, and lenders size the facility around it. Where a transaction has a fixed deadline, a slightly higher margin from a lender that can meet the date is frequently cheaper than a lower margin that misses it and forfeits a deposit or a negotiated purchase price.

Late payment can cause you serious money problems. For help, go to moneyhelper.org.uk.